ORMP·68403P203·US·equity·Healthcare - Biotechnology-Activist
ORMP (ORAMED PHARMACEUTICALS INC) is held by 34 institutional investors as of Q4 2025. Largest holders: DIMENSIONAL FUND ADVISORS LP ($537,735), PNC FINANCIAL SERVICES GROUP, INC. ($72,080), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC ($46,167). Net institutional sentiment: Mixed.
See how ORMP's score breaks down across 4 SEC sources
Showing 7 of 34 results.27 more with Pro.PROUpgrade to see all → |
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer